435 related articles for article (PubMed ID: 21773973)
1. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
[TBL] [Abstract][Full Text] [Related]
2. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experience with transurethral resection of bladder tumor (TUR-Bt) guided by photodynamic diagnosis (PDD)].
Inoue K; Kuno T; Fukuhara H; Hamaguchi T; Fukata S; Karashima T; Kamada M; Shuin T; Sakakura N; Kasahara K; Watanabe H; Kozai T; Yasuda M; Kataoka S; Tanimura M; Atsushi K; Furihata M
Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):661-70. PubMed ID: 19999130
[TBL] [Abstract][Full Text] [Related]
5. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
Burger M; Zaak D; Stief CG; Filbeck T; Wieland WF; Roessler W; Denzinger S
Eur Urol; 2007 Jul; 52(1):142-7. PubMed ID: 17267099
[TBL] [Abstract][Full Text] [Related]
7. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer.
Namikawa T; Inoue K; Uemura S; Shiga M; Maeda H; Kitagawa H; Fukuhara H; Kobayashi M; Shuin T; Hanazaki K
J Surg Oncol; 2014 Mar; 109(3):213-7. PubMed ID: 24214406
[TBL] [Abstract][Full Text] [Related]
9. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficiency of photodynamic diagnostics with topical use of the 3% and 15% aminolevulinic acid in the detection of vulvar lesions.
Maździarz A; Zielińska A; Alkhalayla H; Spiewankiewicz B
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):422-8. PubMed ID: 24284095
[TBL] [Abstract][Full Text] [Related]
11. 'Real-life experience': recurrence rate at 3 years with Hexvix
Gallagher KM; Gray K; Anderson CH; Lee H; Stewart S; Donat R; Mariappan P
World J Urol; 2017 Dec; 35(12):1871-1877. PubMed ID: 28803385
[TBL] [Abstract][Full Text] [Related]
12. Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: identification of patient groups that may benefit most from highly specific optical diagnostics.
Draga RO; Grimbergen MC; Kok ET; Jonges TN; Bosch JL
Urology; 2009 Oct; 74(4):851-6. PubMed ID: 19683800
[TBL] [Abstract][Full Text] [Related]
13. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
14. [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis].
Kausch I; Sommerauer M; Montorsi F; Stenzl A; Jacqmin D; Jichlinski P; Jocham D; Ziegler A; Vonthein R
Aktuelle Urol; 2010 May; 41(3):171-7. PubMed ID: 20486035
[TBL] [Abstract][Full Text] [Related]
15. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Burger M; Stief CG; Zaak D; Stenzl A; Wieland WF; Jocham D; Otto W; Denzinger S
Urology; 2009 Dec; 74(6):1282-6. PubMed ID: 19819538
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer].
Danil'chenko DI; Koenig F; Riedl K; Schnorr D; Waldman A; Al-Shukri S; Loening SA
Vopr Onkol; 2003; 49(6):734-7. PubMed ID: 14976918
[TBL] [Abstract][Full Text] [Related]
17. Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.
Inoue K; Anai S; Fujimoto K; Hirao Y; Furuse H; Kai F; Ozono S; Hara T; Matsuyama H; Oyama M; Ueno M; Fukuhara H; Narukawa M; Shuin T
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):193-200. PubMed ID: 25843912
[TBL] [Abstract][Full Text] [Related]
18. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
Inoue K; Matsuyama H; Fujimoto K; Hirao Y; Watanabe H; Ozono S; Oyama M; Ueno M; Sugimura Y; Shiina H; Mimata H; Azuma H; Nagase Y; Matsubara A; Ito YM; Shuin T
Photodiagnosis Photodyn Ther; 2016 Mar; 13():91-96. PubMed ID: 26751700
[TBL] [Abstract][Full Text] [Related]
19. [Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer].
Matveev BP; Kudashev BV; Bukharkin BV; Romanov VA; Rubanov IuV
Urologiia; 2000; (3):22-4. PubMed ID: 11186703
[TBL] [Abstract][Full Text] [Related]
20. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors.
Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Roessler W
J Urol; 2002 Jul; 168(1):67-71. PubMed ID: 12050494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
